Average Co-Inventor Count = 5.17
ph-index = 13
The patent ph-index is calculated by counting the number of publications for which an author has been cited by other authors at least that same number of times.
Company Filing History:
1. Bristol-myers Squibb Compnay (20 from 3,685 patents)
2. Other (2 from 832,880 patents)
3. Harvard College (1 from 2,968 patents)
4. The General Hospital Corporation (1 from 2,893 patents)
5. Karo Bio Aktiebolag (1 from 2 patents)
23 patents:
1. 10370428 - Methods of treatment using CTLA4 mutant molecules
2. 9758565 - Methods of treatment using CTLA4 mutant molecules
3. 8785398 - Methods of treatment using CTLA4 mutant molecules
4. 7915395 - Expression vectors encoding bispecific fusion proteins and methods of producing biologically active bispecific fusion proteins in a mammalian cell
5. 7829534 - Methods for protecting allogeneic islet transplant using soluble CTLA4 mutant molecules
6. 7700556 - Methods of treatment using CTLA4 mutant molecules
7. 7455835 - Methods for treating immune system diseases using a soluble CTLA4 molecule
8. 7439230 - Methods of treatment using CTLA4 mutant molecules
9. 7304033 - Methods for protecting allogeneic islet transplant using soluble CTLA4 mutant molecules
10. 7105166 - Soluble CTLA4 mutant molecules and uses thereof
11. 7094874 - Soluble CTLA4 mutant molecules
12. 6482919 - Expression vectors encoding bispecific fusion proteins and methods of producing biologically active bispecific fusion proteins in a mammalian cell
13. 6413514 - Methods of using antibodies against human CD40
14. 6372215 - Monoclonal antibodies to human CD6
15. 6312693 - Antibodies against human CD40